Grabien Mobile App
Get Grabien on the go!
  Collapse  

Sirnaomics Receives FDA Approval of IND for Phase 1 Clinical Trial of Systemic RNAi Therapeutic STP707 for Solid Tumor Treatment

GAITHERSBURG, Md. and SUZHOU BIOBAY, China, July 6, 2021 /PRNewswire/ --

Like our work? Support the cause.
$
/